Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy?

With a general bullishness amongst the heavyweights, key money managers have been driving this bullishness. Bow Street LLC established the largest position in Adamas Pharmaceuticals Inc (NASDAQ:ADMS). Bow Street LLC had $18.9 million invested in the company at the end of the quarter. Warren Lammert’s Granite Point Capital also initiated a $3.7 million position during the quarter. The other funds with brand new ADMS positions are Philip Hempleman’s Ardsley Partners and Ken Griffin’s Citadel Investment Group.

Let’s now review hedge fund activity in other stocks similar to Adamas Pharmaceuticals Inc (NASDAQ:ADMS). We will take a look at Columbus McKinnon Corp. (NASDAQ:CMCO), CNX Coal Resources LP (NYSE:CNXC), Triumph Bancorp Inc (NASDAQ:TBK), and Peoples Utah Bancorp (NASDAQ:PUB). All of these stocks’ market caps are similar to ADMS’s market cap.

As you can see these stocks had an average of 7.75 hedge funds with bullish positions and the average amount invested in these stocks was $48 million. That figure was $115 million in ADMS’s case. Columbus McKinnon Corp. (NASDAQ:CMCO) is the most popular stock in this table. On the other hand Peoples Utah Bancorp (NASDAQ:PUB) is the least popular one with only 4 bullish hedge fund positions. Compared to these stocks Adamas Pharmaceuticals Inc (NASDAQ:ADMS) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers and collectively they own nearly one third of the company, it may be a good idea to analyze it in detail and potentially include it in your portfolio.